24A.—(1) Where the CE marking referred to in regulation 24 is affixed on the basis of an assessment or a certificate issued by a notified body established in the United Kingdom, a UK(NI) indication must be affixed in relation to the device, in accordance with this regulation.
(2) The UK(NI) indication must be affixed—
(a)visibly, legibly and indelibly; and
(b)before a relevant medical device is placed on the market in Northern Ireland.
(3) The UK(NI) indication must accompany the CE marking, wherever that is affixed in accordance with regulation 27.
[F2(3A) The UK(NI) indication may be less than 5mm high provided that it is the same height as the CE marking that it accompanies.]
(4) The UK(NI) indication must be affixed by the manufacturer.
(5) Anyone who places a medical device on the market in Northern Ireland must ensure that the manufacturer has complied with their obligations under this regulation.
(6) No person shall supply a relevant device unless the manufacturer has affixed a UK(NI) indication as required by this regulation, if that supply is also a placing on the market or putting into service, or that supply is of a device that has been placed on the market or put into service”;]
Textual Amendments
F1Reg. 24A inserted (N.I.) (31.12.2020 immediately before IP completion day) by The Medical Devices (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1478), reg. 1(3), Sch. 1 para. 9
F2Reg. 24A(3A) inserted (27.7.2021) by The Medical Devices (Northern Ireland Protocol) Regulations 2021 (S.I. 2021/905), regs. 1(2), 36